Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ANTX | AN2 Therapeutics, Inc. | Director | Jun 19, 2024 | |||
VTGN | Vistagen Therapeutics, Inc. | Director | Sep 6, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|